The process of public policy formulation: the case of thimerosal in vaccines

Pediatrics. 2002 Jun;109(6):1153-9. doi: 10.1542/peds.109.6.1153.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Health Policy
  • Humans
  • Thimerosal / adverse effects*
  • United States
  • United States Food and Drug Administration
  • Vaccines / adverse effects
  • Vaccines / chemistry*

Substances

  • Vaccines
  • Thimerosal